Offerings

Vaxart Bags $453M Worth BARDA-Funded Project, Seeks To Raise $40M Via Equity Offering
Trump Media & Technology Group Stock Is Sliding Monday: What's Going On?
What's Going On With DraftKings Stock?
Trump Media & Technology Group Stock Is Sliding Monday: What's Going On?
What's Going On With DraftKings Stock?
How These 2 Nasdaq-Listed Marijuana Companies Found A Way To Raise $250M Without Tanking Their Stock
EXCLUSIVE - Canopy Growth CFO On ATM Equity Offering: 'We Have One Of The Strongest Balance Sheets In Cannabis'

Offerings Recent News

Trip.Com Stock Is Trading Lower Tuesday: What's Going On?
Trip.com Group Limited (NASDAQ: TCOM) to offer $1.3 billion in convertible senior notes to repay debt and expand operations, while repurchasing shares.
Why GameStop Shares Are Rallying Friday
GameStop shares are trading higher Friday after market close. The company shared a company update that was well received by investors.
Heart Disease-Focused Cytokinetics Operations Are On Track Despite Acquisition Uncertainty, Analysts Observe
Unlock the latest on Royalty Pharma plc & Cytokinetics Inc.'s strategic funding collaboration for aficamten's commercialization and cardiovascular pipeline expansion.
What's Going On With Alibaba Stock On Thursday?
Alibaba Group (NYSE: BABA) is considering a $5 billion convertible bond sale, following rival JD's move. This could fund share repurchases and growth. BABA's ADRs have dropped 6.6% this week. Reports of bearish sentiment from U.S. short sellers may have caused this. BABA reported 7% revenue growth in Q4 2023. BABA stock has lost 0.24% in the last 12 months.
Popular Tech YouTuber Linus Sebastian Says Months-Long Investigation Finds Ex-Employee's Harassment Claims 'Not Substantiated'
Popular tech YouTuber Linus Sebastian's Linus Tech Tips (LTT) has revealed the findings of an external investigation, noting that it disproved the allegations made by a former employee.
GlobalFoundries Launches $950 Million Secondary Offering
GlobalFoundries announced asecondary public offering of $950 million of its ordinary shares and a concurrent $200 million share repurchase.
What's Going On With GT Biopharma Stock Tuesday?
GT Biopharma entered into a definitive securities purchase agreement for the purchase and sale of 740,000 shares of its common stock at a purchase price of $4.35 per share. The shares will be offered in a registered direct offering priced at-the-market under Nasdaq rules.
Why Is GameStop Stock Crashing Premarket After Early Gains? (CORRECTED)
GameStop filed a prospectus with the SEC for an "at-the-market" offering, allowing them to sell up to 45 million common shares.
Nano-Cap Eledon Pharmaceuticals' Investigational Drug Shows Safety In Early Organ Transplant Study, Analyst Boosts Forecast On Increased Confidence
Eledon Pharmaceuticals' results from islet cell transplant trial for type 1 diabetes, with tegoprubart showing safety and efficacy in kidney transplant patients. Analysts anticipate significant advancements, reflecting in raised price targets.
Alzamend Neuro Halts Equity Offering Program, Prioritizing Shareholder Value Amid Strategic Shift, Shares Slide
Alzemend Neuro made waves Tuesday when the company announced its decision to terminate its "at-the-market" equity offering program. Shares were down nearly 12% at last check.
UMB Financial Is Down After Largest Acquisition In Its 111-Year History - Here's Why
UMB Financial shares down after inking acquisition deal, pricing offering, and reporting Q1 FY24 results.
Cullinan Shifts Focus From Oncology To Autoimmune Disorders, Raises $280M Via Equity
Cullinan shifts focus to autoimmune diseases with CLN-978, targeting systemic lupus erythematosus. Initial trial results show potential for treatment with a differentiated safety profile.
Why Barnes & Noble Education Shares Are Diving Today
Barnes & Noble Education, Inc. announces a rights plan & equity investment to strengthen balance sheet. Stock down 65.7% at $0.2400.

Explore Benzinga's Financial Tools

Find Stocks Tailored to Your Trading Interests
Find Stocks Tailored to Your Trading Interests
Benzinga Pro offers a real-time newsfeed as headlines break on earnings releases, analyst ratings, rumors, the biggest movers, and many more actionable alerts.

Compare Benzinga's Favorite Stock Brokers

Claim Exclusive Offers

Compare Benzinga's Favorite Cryptocurrency Brokers

Claim Exclusive Offers